• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/096 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Patent holdings for IPC class C07D 295/096

Total number of patents in this class: 348

10-year publication summary

44
38
40
26
20
28
17
21
10
1
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
H. Lundbeck A/S
1244
28
Lek Pharmaceuticals d.d.
210
9
vTv Therapeutics LLC
154
9
Novartis AG
11254
8
The Johns Hopkins University
5540
7
Cardioxyl Pharmaceuticals, Inc.
49
7
Reneo Pharmaceuticals, Inc.
23
7
Johnson Matthey Public Limited Company
1861
5
Emory University
1592
4
Metabolys
7
4
Sunshine Lake Pharma Co., Ltd.
572
4
Bristol-myers Squibb Company
4861
3
Sandoz AG
1404
3
National Institute of Advanced Industrial Science and Technology
3736
3
University of Florida Research Foundation, Inc.
3965
3
Ben-Gurion University of the Negev Research and Development Authority
213
3
Biogen MA Inc.
917
3
Cadila Healthcare Limited
323
3
Sutter Bay Hospitals
15
3
Teijin Pharma Limited
251
3
Other owners 229